These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 25580924

  • 1. Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study.
    Kertesz DP, Swartz MV, Tadger S, Plopski I, Barak Y.
    Clin Neuropharmacol; 2015; 38(1):23-5. PubMed ID: 25580924
    [Abstract] [Full Text] [Related]

  • 2. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ, Ondo WG, Dashtipour K, Swope DM.
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [Abstract] [Full Text] [Related]

  • 3. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Jankovic J, Clarence-Smith K.
    Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
    [Abstract] [Full Text] [Related]

  • 4. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C, Hunter C, Jankovic J.
    Mov Disord; 2007 Jan 15; 22(2):193-7. PubMed ID: 17133512
    [Abstract] [Full Text] [Related]

  • 5. Tetrabenazine treatment for Huntington's disease-associated chorea.
    Ondo WG, Tintner R, Thomas M, Jankovic J.
    Clin Neuropharmacol; 2002 Jan 15; 25(6):300-2. PubMed ID: 12469001
    [Abstract] [Full Text] [Related]

  • 6. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.
    Frank S.
    BMC Neurol; 2009 Dec 18; 9():62. PubMed ID: 20021666
    [Abstract] [Full Text] [Related]

  • 7. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2013 Oct 10; 250():507-19. PubMed ID: 23867769
    [Abstract] [Full Text] [Related]

  • 8. Tetrabenazine.
    Fasano A, Bentivoglio AR.
    Expert Opin Pharmacother; 2009 Dec 10; 10(17):2883-96. PubMed ID: 19929707
    [Abstract] [Full Text] [Related]

  • 9. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J.
    Clin Neuropharmacol; 2008 Dec 10; 31(3):127-33. PubMed ID: 18520979
    [Abstract] [Full Text] [Related]

  • 10. Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial.
    Remington G, Kapur S, Foussias G, Agid O, Mann S, Borlido C, Richards S, Javaid N.
    J Clin Psychopharmacol; 2012 Feb 10; 32(1):95-9. PubMed ID: 22198452
    [Abstract] [Full Text] [Related]

  • 11. Tardive tremor.
    Stacy M, Jankovic J.
    Mov Disord; 1992 Feb 10; 7(1):53-7. PubMed ID: 1348352
    [Abstract] [Full Text] [Related]

  • 12. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A, Cadeddu F, Guidubaldi A, Piano C, Soleti F, Zinzi P, Bentivoglio AR.
    Clin Neuropharmacol; 2008 Feb 10; 31(6):313-8. PubMed ID: 19050408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG, Breden EL.
    Ann Pharmacother; 2011 Apr 10; 45(4):525-31. PubMed ID: 21487088
    [Abstract] [Full Text] [Related]

  • 15. Tetrabenazine therapy of pediatric hyperkinetic movement disorders.
    Jain S, Greene PE, Frucht SJ.
    Mov Disord; 2006 Nov 10; 21(11):1966-72. PubMed ID: 16958131
    [Abstract] [Full Text] [Related]

  • 16. Sensory trick with metoclopramide-associated tardive tremor.
    Shprecher D.
    BMJ Case Rep; 2012 Sep 07; 2012():. PubMed ID: 22962383
    [Abstract] [Full Text] [Related]

  • 17. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.
    Kegelmeyer DA, Kloos AD, Fritz NE, Fiumedora MM, White SE, Kostyk SK.
    J Neurol Sci; 2014 Dec 15; 347(1-2):219-23. PubMed ID: 25456459
    [Abstract] [Full Text] [Related]

  • 18. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C, Hunter C, Davidson A, Jankovic J.
    Mov Disord; 2007 Jan 15; 22(1):10-3. PubMed ID: 17078062
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.